HERON TECHNOLOGY Announces Application for Medical Device Product Registration of “Benu” Neutron Radiation System with Singapore’s Health Sciences Authority (HSA)
NQ Score
0/100
AI Summary (NQ-processed)
HERON TECHNOLOGY has submitted an application to the Singapore Health Sciences Authority (HSA) for the medical device product registration of its “Benu” Neutron Radiation System. The company has authorized its Singapore subsidiary, HERON NEUTRON MEDICAL SINGAPORE PTE. LTD., to act as the local registrant, handling all regulatory processes. The “Benu” Neutron Radiation System utilizes Boron Neutron Capture Therapy (BNCT), an advanced radiation therapy that precisely targets and destroys tumor cells with minimal harm to healthy tissues, offering a promising treatment for cancers like recurrent head and neck cancer and glioblastoma.
AI analysis data is not yet available.